UroGen Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of UroGen Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $-0.55 | $-0.82 | 32.9 % |
Jun 2024 | 2024-08-13 | $-0.91 | $-0.84 | -8.33 % |
Mar 2024 | 2024-05-13 | $-0.97 | $-0.87 | -11.5 % |
Dec 2023 | 2024-03-14 | $-0.72 | $-0.68 | -5.88 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $25.20M | $24.20M | 4.15 % |
Jun 2024 | 2024-08-13 | $21.85M | $23.76M | -8.05 % |
Mar 2024 | 2024-05-13 | $18.78M | $21.38M | -12.2 % |
Dec 2023 | 2024-03-14 | $23.53M | $22.57M | 4.25 % |
UroGen Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3.
UroGen Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was $-0.55, which beat the estimate of $-0.82.
UroGen Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 6, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.